Gotta Go: How LexaGene is Keeping Your Cat and Dog’s Urology Healthy

by | Nov 18, 2021 | Veterinary Diagnostics

Home » Veterinary Diagnostics » Gotta Go: How LexaGene is Keeping Your Cat and Dog’s Urology Healthy

About Urinary Tract Infections

Urinary Tract Infections (UTIs) are the most common infectious disease in dogs, affecting approximately 14 percent of dogs during their lifetime. UTIs are commonly caused by E. coli, Streptococcus, Proteus, Klebsiella, and Pseudomonas in dogs. Due to the short doubling time of these pathogens, they can evolve rapidly in response to environmental stresses, whether it is the host’s immune system or prescribed antibiotics. Such evolution can turn benign bacteria into a virulent, drug-resistant form and threaten the animal’s life.

Dog Urinary Tract Infection

Many bacteria are common in the environment and are often found in healthy animals’ intestines, on their skin, mucosal surfaces, and nasal passageways. The genetic makeup of these bacteria is very diverse. Most of these bacteria have strains that have evolved to be resistant to one or more classes of antibiotics. Some are multi-drug resistant (MDR), as they are resistant to three or more classes of antibiotics.

In addition to UTIs, these bacteria cause pneumonia, bloodstream infections, and surgical site infections, which are important to veterinarians.

LexaGene developed assays for pathogen detection and whether they possess drug resistant genes.  Our market research indicates veterinarians and clinicians want technology to enable them to determine the cause of a UTI and other types of infections quickly, while identifying antibiotic resistant genes, so they can provide the appropriate therapy upon the first visit to the veterinary clinic.

This point of care diagnostics allows for a much better outcome than traditional culture and sensitivity testing, which requires waiting three to five days for results. During this time, the animal’s condition may deteriorate.

LexaGene’s MiQLab™ veterinary diagnostic technology allows veterinarians to better care for their patients by arriving at a correct diagnosis faster and minimizing unsuccessful treatment pathways.

Download Our Antimicrobial Resistance in Veterinary Medicine Infographic to Learn More

<a href="https://lexagene.com/author/juliegriggs/" target="_self">Julie Griggs</a>

Julie Griggs

Julie Griggs represents LexaGene’s Western sales territory. She comes to us with deep experience, having begun her career in the veterinary industry working as a technician in small animal practice. In 1998, she became a Certified Veterinary Technician. Julie became a Practice Manager for an extensive general veterinary practice in the U.S. whose portfolio represented more than 1,000 hospitals in neighborhoods across the country and Puerto Rico. She also held key positions in other veterinary market organizations. Along the way, Julie observed the industry’s desire for advancements that would enable veterinarians to offer the highest quality of care for companion animals and the families who love them.

Survey Says Veterinarians Have an Appetite for In-Clinic Diagnostic Technology

This spring LexaGene conducted a market research survey in conjunction with AAHA to assess the opinions of practicing veterinarians on AMR stewardship and the use of antibiotics in the treatment of companion animals.

The Dawn of the Superbugs

The most menacing of all resistant bacteria are the so called “super bugs”- strains of bacteria that are resistant to several different classes of antibiotics or multidrug resistant.

LexaGene offers North Shore Technology Council (NSTC) and Leadership Team at MassBio a tour of our Beverly Facility

Recently, we welcomed members of North Shore Technology Council and MassBio Leadership Teams into our facility at 500 Cummings Center for a full tour of our office space and laboratory spaces.

Upcoming Events

LexaGene will be exhibiting AAHA's Connexity Event in September.
1 2 3 8

Latest Resources


In this webinar, Dr. Jane Sykes details data from a multi-center study using the MiQLab® System for diagnosing urinary tract infections.
1 2 3 28